Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
Clinical trial NCT03140527 · COMPLETED
Trial details
- NCT number
- NCT03140527
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2020-02-27
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.